Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myositis, Inclusion Body | 44 | 2023 | 147 | 16.280 |
Why?
|
Myositis | 18 | 2023 | 251 | 4.610 |
Why?
|
Dermatomyositis | 19 | 2022 | 224 | 4.610 |
Why?
|
Interferon Type I | 15 | 2022 | 542 | 2.730 |
Why?
|
Muscle, Skeletal | 38 | 2023 | 4935 | 2.480 |
Why?
|
Polymyositis | 10 | 2013 | 75 | 2.370 |
Why?
|
Muscle Fibers, Skeletal | 8 | 2020 | 555 | 1.820 |
Why?
|
5'-Nucleotidase | 6 | 2020 | 160 | 1.780 |
Why?
|
Interferon-beta | 8 | 2017 | 323 | 1.590 |
Why?
|
Lectins, C-Type | 5 | 2022 | 588 | 0.960 |
Why?
|
Neuromuscular Diseases | 6 | 2014 | 253 | 0.920 |
Why?
|
Autoantibodies | 8 | 2020 | 2038 | 0.870 |
Why?
|
Receptors, Immunologic | 6 | 2022 | 1423 | 0.860 |
Why?
|
Muscle Proteins | 6 | 2011 | 1159 | 0.860 |
Why?
|
Muscle Weakness | 6 | 2013 | 415 | 0.830 |
Why?
|
Lichen Planus, Oral | 1 | 2022 | 56 | 0.820 |
Why?
|
Scapula | 2 | 2013 | 164 | 0.800 |
Why?
|
Guillain-Barre Syndrome | 3 | 2014 | 123 | 0.780 |
Why?
|
Autoimmune Diseases | 4 | 2023 | 2136 | 0.740 |
Why?
|
Leukemia, Large Granular Lymphocytic | 2 | 2020 | 18 | 0.740 |
Why?
|
Interferon-alpha | 8 | 2013 | 895 | 0.650 |
Why?
|
Cytokines | 8 | 2019 | 7326 | 0.650 |
Why?
|
Myasthenia Gravis | 2 | 2015 | 201 | 0.620 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2022 | 1821 | 0.610 |
Why?
|
Oligonucleotide Array Sequence Analysis | 16 | 2012 | 3921 | 0.580 |
Why?
|
Follistatin | 1 | 2017 | 141 | 0.570 |
Why?
|
Sarcoplasmic Reticulum | 3 | 2014 | 158 | 0.540 |
Why?
|
Lambert-Eaton Myasthenic Syndrome | 1 | 2015 | 8 | 0.520 |
Why?
|
Cell Nucleus | 5 | 2014 | 2969 | 0.520 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 2 | 2013 | 61 | 0.510 |
Why?
|
Ubiquitins | 3 | 2013 | 384 | 0.490 |
Why?
|
Motor Neuron Disease | 1 | 2015 | 106 | 0.490 |
Why?
|
Immunoglobulin Isotypes | 1 | 2014 | 158 | 0.480 |
Why?
|
Nitrous Oxide | 1 | 2015 | 177 | 0.480 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2015 | 116 | 0.470 |
Why?
|
Autoantigens | 4 | 2013 | 892 | 0.470 |
Why?
|
Median Nerve | 1 | 2014 | 132 | 0.470 |
Why?
|
Vitamin B 12 | 2 | 2015 | 527 | 0.460 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4477 | 0.450 |
Why?
|
Zinc | 2 | 2010 | 683 | 0.450 |
Why?
|
Publication Bias | 2 | 2011 | 162 | 0.450 |
Why?
|
Muscles | 2 | 2016 | 1622 | 0.430 |
Why?
|
Plasma Cells | 4 | 2014 | 591 | 0.430 |
Why?
|
Muscular Diseases | 5 | 2010 | 557 | 0.420 |
Why?
|
Dendritic Cells | 5 | 2012 | 2725 | 0.420 |
Why?
|
Ataxia | 1 | 2014 | 304 | 0.420 |
Why?
|
Humans | 105 | 2023 | 744220 | 0.420 |
Why?
|
Isoantibodies | 1 | 2016 | 681 | 0.410 |
Why?
|
Carpal Tunnel Syndrome | 2 | 2014 | 300 | 0.410 |
Why?
|
Myokymia | 1 | 2011 | 11 | 0.410 |
Why?
|
DEAD-box RNA Helicases | 1 | 2014 | 375 | 0.400 |
Why?
|
Fasciitis | 1 | 2012 | 65 | 0.400 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 381 | 0.390 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2011 | 37 | 0.390 |
Why?
|
Movement Disorders | 1 | 2014 | 445 | 0.380 |
Why?
|
Gene Expression Profiling | 13 | 2012 | 9438 | 0.380 |
Why?
|
Carboxymethylcellulose Sodium | 1 | 2010 | 39 | 0.380 |
Why?
|
Vacuoles | 2 | 2013 | 230 | 0.380 |
Why?
|
Up-Regulation | 6 | 2019 | 4217 | 0.370 |
Why?
|
Proteomics | 4 | 2012 | 3637 | 0.370 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2005 | 602 | 0.360 |
Why?
|
Gene Expression | 7 | 2014 | 7799 | 0.360 |
Why?
|
Muscle Cells | 2 | 2012 | 196 | 0.350 |
Why?
|
Sarcomeres | 2 | 2009 | 374 | 0.350 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 2009 | 69 | 0.340 |
Why?
|
Scleroderma, Systemic | 4 | 2014 | 323 | 0.340 |
Why?
|
Antibodies, Monoclonal | 5 | 2014 | 9275 | 0.340 |
Why?
|
Immunologic Factors | 4 | 2020 | 1582 | 0.330 |
Why?
|
T-Lymphocytes | 6 | 2020 | 10182 | 0.330 |
Why?
|
Autoimmunity | 3 | 2013 | 1349 | 0.320 |
Why?
|
Nervous System Diseases | 3 | 2004 | 1623 | 0.320 |
Why?
|
Antibodies, Neoplasm | 1 | 2009 | 286 | 0.320 |
Why?
|
Enzymes | 1 | 2009 | 266 | 0.300 |
Why?
|
Skin | 4 | 2010 | 4363 | 0.300 |
Why?
|
Gadolinium DTPA | 1 | 2010 | 836 | 0.290 |
Why?
|
Transcriptional Activation | 2 | 2010 | 1782 | 0.290 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 1 | 2007 | 48 | 0.290 |
Why?
|
Microarray Analysis | 2 | 2014 | 766 | 0.280 |
Why?
|
Microdissection | 4 | 2010 | 152 | 0.280 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2009 | 1121 | 0.270 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2007 | 374 | 0.270 |
Why?
|
Cell Differentiation | 4 | 2019 | 11478 | 0.270 |
Why?
|
Inclusion Bodies | 3 | 2019 | 279 | 0.260 |
Why?
|
Neurology | 2 | 2004 | 764 | 0.260 |
Why?
|
Antigens, CD | 1 | 2016 | 4026 | 0.260 |
Why?
|
Immunohistochemistry | 8 | 2014 | 11368 | 0.260 |
Why?
|
Polyradiculoneuropathy | 2 | 2002 | 67 | 0.260 |
Why?
|
Models, Immunological | 1 | 2007 | 527 | 0.250 |
Why?
|
Ventilator Weaning | 1 | 2006 | 148 | 0.250 |
Why?
|
B-Lymphocytes | 4 | 2011 | 4665 | 0.240 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2014 | 33 | 0.240 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2014 | 1596 | 0.230 |
Why?
|
DNA-Binding Proteins | 5 | 2014 | 9647 | 0.230 |
Why?
|
Meningioma | 1 | 2012 | 1209 | 0.230 |
Why?
|
Adenosine Triphosphatases | 1 | 2007 | 839 | 0.220 |
Why?
|
Polymers | 1 | 2010 | 1620 | 0.220 |
Why?
|
GTP-Binding Proteins | 4 | 2010 | 970 | 0.220 |
Why?
|
Ultrasonography | 2 | 2021 | 5982 | 0.210 |
Why?
|
RNA, Messenger | 8 | 2017 | 13036 | 0.210 |
Why?
|
Immunity, Innate | 1 | 2014 | 2958 | 0.210 |
Why?
|
Male | 38 | 2019 | 350027 | 0.210 |
Why?
|
Thymoma | 1 | 2004 | 186 | 0.210 |
Why?
|
Biopsy | 8 | 2012 | 6757 | 0.210 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2001 | 26 | 0.210 |
Why?
|
Myeloid Cells | 1 | 2007 | 809 | 0.200 |
Why?
|
Publishing | 1 | 2009 | 833 | 0.200 |
Why?
|
Cytosol | 2 | 2017 | 901 | 0.200 |
Why?
|
Signal Transduction | 7 | 2022 | 23404 | 0.200 |
Why?
|
Thymus Neoplasms | 1 | 2004 | 268 | 0.200 |
Why?
|
Copper | 1 | 2004 | 366 | 0.190 |
Why?
|
Middle Aged | 28 | 2019 | 213367 | 0.190 |
Why?
|
Electromyography | 4 | 2016 | 1391 | 0.190 |
Why?
|
Artificial Intelligence | 1 | 2014 | 2213 | 0.190 |
Why?
|
Myoblasts | 1 | 2022 | 238 | 0.190 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2002 | 288 | 0.190 |
Why?
|
Nervous System | 1 | 2004 | 554 | 0.180 |
Why?
|
Data Collection | 1 | 2009 | 3340 | 0.180 |
Why?
|
Receptor, Interferon alpha-beta | 2 | 2010 | 107 | 0.180 |
Why?
|
tau Proteins | 1 | 2009 | 1868 | 0.180 |
Why?
|
Hematologic Diseases | 1 | 2004 | 498 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 8 | 2022 | 35423 | 0.170 |
Why?
|
Mass Spectrometry | 3 | 2013 | 2204 | 0.170 |
Why?
|
Gene Expression Regulation | 9 | 2012 | 12075 | 0.170 |
Why?
|
Amyloid beta-Peptides | 2 | 2009 | 3585 | 0.170 |
Why?
|
Fluorescent Antibody Technique | 3 | 2014 | 2505 | 0.160 |
Why?
|
Aged | 20 | 2018 | 163253 | 0.160 |
Why?
|
Sjogren's Syndrome | 1 | 2020 | 233 | 0.160 |
Why?
|
Female | 34 | 2020 | 380197 | 0.150 |
Why?
|
Immunoglobulins | 3 | 2014 | 881 | 0.150 |
Why?
|
Respiratory Insufficiency | 1 | 2006 | 1199 | 0.150 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 1 | 1996 | 22 | 0.150 |
Why?
|
Immunoblotting | 2 | 2011 | 1682 | 0.150 |
Why?
|
Carcinoma, Renal Cell | 1 | 2012 | 3130 | 0.150 |
Why?
|
Adult | 29 | 2020 | 214035 | 0.140 |
Why?
|
Larynx | 1 | 2021 | 494 | 0.140 |
Why?
|
Arsenic Poisoning | 1 | 1996 | 55 | 0.140 |
Why?
|
South Australia | 1 | 2016 | 19 | 0.140 |
Why?
|
Neural Conduction | 2 | 2011 | 468 | 0.140 |
Why?
|
Microscopy, Immunoelectron | 2 | 2007 | 319 | 0.140 |
Why?
|
Myelin Proteins | 1 | 1996 | 215 | 0.140 |
Why?
|
Chemokine CXCL10 | 1 | 2017 | 304 | 0.140 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3461 | 0.140 |
Why?
|
Trachea | 1 | 2021 | 1075 | 0.130 |
Why?
|
Databases, Genetic | 3 | 2010 | 1782 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3871 | 0.130 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4245 | 0.130 |
Why?
|
Chromatography, Liquid | 2 | 2009 | 977 | 0.130 |
Why?
|
Lymphocytosis | 1 | 2016 | 119 | 0.130 |
Why?
|
Biomedical Research | 1 | 2011 | 3311 | 0.130 |
Why?
|
Peripheral Nervous System Diseases | 3 | 1996 | 700 | 0.130 |
Why?
|
Nuclear Proteins | 2 | 2007 | 5853 | 0.130 |
Why?
|
Diagnosis, Differential | 4 | 2015 | 12961 | 0.120 |
Why?
|
Smad2 Protein | 1 | 2014 | 156 | 0.120 |
Why?
|
Smad3 Protein | 1 | 2014 | 180 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21672 | 0.120 |
Why?
|
Antibodies, Blocking | 1 | 2014 | 254 | 0.120 |
Why?
|
Demyelinating Diseases | 1 | 1996 | 363 | 0.120 |
Why?
|
Activin Receptors, Type II | 1 | 2014 | 127 | 0.120 |
Why?
|
Immune System | 2 | 2010 | 805 | 0.120 |
Why?
|
Myofibrils | 1 | 2014 | 146 | 0.120 |
Why?
|
B-Cell Maturation Antigen | 2 | 2014 | 140 | 0.110 |
Why?
|
Immunosuppressive Agents | 3 | 2017 | 4151 | 0.110 |
Why?
|
Thigh | 1 | 2014 | 247 | 0.110 |
Why?
|
Research Design | 1 | 2009 | 5987 | 0.110 |
Why?
|
Myopathies, Nemaline | 2 | 2004 | 72 | 0.110 |
Why?
|
Myelitis, Transverse | 1 | 2013 | 39 | 0.110 |
Why?
|
Down-Regulation | 3 | 2012 | 3001 | 0.110 |
Why?
|
Osteitis Deformans | 1 | 2013 | 53 | 0.110 |
Why?
|
Antigen Presentation | 2 | 2010 | 1284 | 0.110 |
Why?
|
Brain Neoplasms | 3 | 2012 | 8860 | 0.110 |
Why?
|
Critical Care | 1 | 2006 | 2644 | 0.110 |
Why?
|
Creatine Kinase | 2 | 2012 | 694 | 0.110 |
Why?
|
Glycolysis | 2 | 2009 | 826 | 0.110 |
Why?
|
Molecular Weight | 1 | 2014 | 2255 | 0.100 |
Why?
|
Epitope Mapping | 1 | 2013 | 311 | 0.100 |
Why?
|
Antigens, Surface | 2 | 2007 | 1663 | 0.100 |
Why?
|
Homocysteine | 1 | 2015 | 647 | 0.100 |
Why?
|
Prions | 1 | 2013 | 181 | 0.100 |
Why?
|
Point Mutation | 1 | 1996 | 1624 | 0.100 |
Why?
|
History, 19th Century | 2 | 2004 | 720 | 0.100 |
Why?
|
Phosphorylation | 2 | 2014 | 8437 | 0.100 |
Why?
|
Mutant Proteins | 1 | 2013 | 500 | 0.100 |
Why?
|
Neuromuscular Agents | 1 | 2012 | 134 | 0.090 |
Why?
|
Muscular Atrophy | 1 | 2014 | 350 | 0.090 |
Why?
|
Membrane Glycoproteins | 3 | 2007 | 3769 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4752 | 0.090 |
Why?
|
Chelation Therapy | 1 | 2010 | 67 | 0.090 |
Why?
|
B-Cell Activating Factor | 1 | 2010 | 119 | 0.090 |
Why?
|
Immunoprecipitation | 1 | 2013 | 905 | 0.090 |
Why?
|
Glycogen Storage Disease Type III | 1 | 2009 | 13 | 0.090 |
Why?
|
Frontotemporal Dementia | 1 | 2013 | 248 | 0.090 |
Why?
|
Animals | 12 | 2019 | 168788 | 0.090 |
Why?
|
Congo Red | 1 | 2009 | 47 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1836 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2006 | 7879 | 0.090 |
Why?
|
Organ Size | 1 | 2014 | 2252 | 0.090 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 279 | 0.090 |
Why?
|
Autocrine Communication | 1 | 2010 | 171 | 0.080 |
Why?
|
Lymphoid Tissue | 1 | 2010 | 455 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 17449 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2001 | 1971 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2019 | 19227 | 0.080 |
Why?
|
Toll-Like Receptor 9 | 1 | 2010 | 212 | 0.080 |
Why?
|
Choristoma | 1 | 2010 | 213 | 0.080 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 167 | 0.080 |
Why?
|
Calpain | 1 | 2009 | 150 | 0.080 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2010 | 708 | 0.080 |
Why?
|
Syndecan-1 | 2 | 2007 | 165 | 0.080 |
Why?
|
Actinin | 1 | 2009 | 160 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4803 | 0.080 |
Why?
|
Nuclear Envelope | 1 | 2009 | 172 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2012 | 2715 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25043 | 0.080 |
Why?
|
Cell Count | 2 | 2010 | 1854 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2011 | 2103 | 0.080 |
Why?
|
Germinal Center | 1 | 2010 | 377 | 0.080 |
Why?
|
RecQ Helicases | 1 | 2007 | 54 | 0.080 |
Why?
|
Leukocytes | 2 | 2013 | 2040 | 0.080 |
Why?
|
Cross Reactions | 1 | 2009 | 841 | 0.080 |
Why?
|
Mutation | 3 | 2013 | 29784 | 0.080 |
Why?
|
Solubility | 1 | 2009 | 1083 | 0.080 |
Why?
|
Biological Assay | 1 | 2010 | 652 | 0.080 |
Why?
|
Myosin Heavy Chains | 1 | 2009 | 414 | 0.080 |
Why?
|
Cohort Studies | 5 | 2019 | 40559 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2009 | 411 | 0.070 |
Why?
|
Antibody Specificity | 1 | 2009 | 1095 | 0.070 |
Why?
|
Neurofilament Proteins | 1 | 2009 | 318 | 0.070 |
Why?
|
Cell Lineage | 2 | 2007 | 2504 | 0.070 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7723 | 0.070 |
Why?
|
Immunoglobulin Switch Region | 1 | 2007 | 46 | 0.070 |
Why?
|
Databases, Protein | 1 | 2009 | 383 | 0.070 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2010 | 449 | 0.070 |
Why?
|
DNA Probes | 2 | 2005 | 560 | 0.070 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.070 |
Why?
|
Exercise Test | 1 | 2014 | 2075 | 0.070 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 520 | 0.070 |
Why?
|
Prospective Studies | 4 | 2021 | 53280 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1801 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3527 | 0.070 |
Why?
|
Review Literature as Topic | 1 | 2009 | 336 | 0.070 |
Why?
|
Exodeoxyribonucleases | 1 | 2007 | 180 | 0.070 |
Why?
|
Endopeptidases | 1 | 2010 | 772 | 0.070 |
Why?
|
Video Recording | 1 | 2011 | 947 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 4465 | 0.070 |
Why?
|
Syndecans | 1 | 2005 | 79 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2014 | 57768 | 0.070 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2007 | 186 | 0.070 |
Why?
|
History, 20th Century | 2 | 2004 | 2739 | 0.070 |
Why?
|
Lamin Type A | 1 | 2006 | 190 | 0.070 |
Why?
|
B-Lymphocyte Subsets | 1 | 2007 | 246 | 0.070 |
Why?
|
Lasers | 1 | 2010 | 952 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2022 | 15538 | 0.060 |
Why?
|
Dystrophin | 1 | 2006 | 285 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2010 | 1731 | 0.060 |
Why?
|
Organ Specificity | 1 | 2010 | 2007 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2008 | 675 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 986 | 0.060 |
Why?
|
Spinal Cord | 2 | 2004 | 1809 | 0.060 |
Why?
|
Atrophy | 1 | 2009 | 1582 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3209 | 0.060 |
Why?
|
Rheumatic Diseases | 1 | 2011 | 593 | 0.060 |
Why?
|
Amyloid | 1 | 2009 | 795 | 0.060 |
Why?
|
Genome | 1 | 2013 | 1808 | 0.060 |
Why?
|
London | 1 | 2004 | 233 | 0.060 |
Why?
|
Complement Membrane Attack Complex | 1 | 2004 | 112 | 0.060 |
Why?
|
Muscle Contraction | 2 | 2012 | 1241 | 0.060 |
Why?
|
Ceruloplasmin | 1 | 2004 | 56 | 0.060 |
Why?
|
Pedigree | 1 | 2012 | 4648 | 0.060 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2020 | 658 | 0.060 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2007 | 548 | 0.060 |
Why?
|
Liver | 1 | 2019 | 7472 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2014 | 12035 | 0.060 |
Why?
|
Proteins | 2 | 2010 | 6101 | 0.060 |
Why?
|
Vital Capacity | 1 | 2006 | 926 | 0.060 |
Why?
|
Molecular Biology | 1 | 2007 | 596 | 0.060 |
Why?
|
Microscopy, Electron | 1 | 2006 | 2645 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2011 | 39045 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2008 | 972 | 0.050 |
Why?
|
Protein Kinases | 1 | 2010 | 1639 | 0.050 |
Why?
|
Proteoglycans | 1 | 2005 | 835 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2007 | 736 | 0.050 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2013 | 1423 | 0.050 |
Why?
|
Cell Line | 2 | 2014 | 15999 | 0.050 |
Why?
|
Genomics | 2 | 2012 | 5722 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6474 | 0.050 |
Why?
|
Tracheostomy | 1 | 2006 | 400 | 0.050 |
Why?
|
Artifacts | 1 | 2010 | 1903 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4419 | 0.050 |
Why?
|
Immunotherapy | 3 | 2012 | 4440 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2016 | 21752 | 0.050 |
Why?
|
Alopecia Areata | 1 | 2004 | 107 | 0.050 |
Why?
|
Blotting, Western | 1 | 2009 | 5180 | 0.050 |
Why?
|
Palate, Soft | 1 | 2021 | 96 | 0.050 |
Why?
|
Laboratories | 1 | 2005 | 463 | 0.050 |
Why?
|
Antibodies | 1 | 2009 | 2461 | 0.050 |
Why?
|
Capillaries | 1 | 2004 | 774 | 0.050 |
Why?
|
MicroRNAs | 2 | 2014 | 3747 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1838 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 1903 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 7908 | 0.050 |
Why?
|
Cell Movement | 1 | 2012 | 5216 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2005 | 2256 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6172 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6612 | 0.050 |
Why?
|
Peripheral Nerves | 1 | 2004 | 477 | 0.050 |
Why?
|
Vaccination | 1 | 2012 | 3278 | 0.040 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2002 | 256 | 0.040 |
Why?
|
Young Adult | 4 | 2015 | 56436 | 0.040 |
Why?
|
Treatment Failure | 1 | 2006 | 2619 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2916 | 0.040 |
Why?
|
Hand Strength | 1 | 2022 | 448 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2915 | 0.040 |
Why?
|
Proteome | 1 | 2009 | 1798 | 0.040 |
Why?
|
Blood Vessels | 1 | 2005 | 1126 | 0.040 |
Why?
|
Multigene Family | 1 | 2002 | 1102 | 0.040 |
Why?
|
Uncertainty | 1 | 2004 | 734 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 2 | 2011 | 3712 | 0.040 |
Why?
|
Perforin | 1 | 2019 | 168 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1575 | 0.040 |
Why?
|
Gene Deletion | 1 | 2007 | 2751 | 0.040 |
Why?
|
Prednisolone | 1 | 2020 | 334 | 0.040 |
Why?
|
Inclusion Bodies, Viral | 1 | 2018 | 45 | 0.040 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2019 | 97 | 0.040 |
Why?
|
Gene Library | 1 | 2001 | 1076 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2010 | 2727 | 0.040 |
Why?
|
Azathioprine | 1 | 2020 | 355 | 0.040 |
Why?
|
Neutropenia | 1 | 2004 | 895 | 0.040 |
Why?
|
Vasculitis | 1 | 2002 | 521 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 271 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4455 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2018 | 77426 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2014 | 63119 | 0.040 |
Why?
|
Hepatitis | 1 | 2019 | 227 | 0.040 |
Why?
|
Metabolic Diseases | 1 | 2004 | 658 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2022 | 1880 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4407 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3508 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2009 | 2957 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2010 | 5021 | 0.040 |
Why?
|
Nystagmus, Pathologic | 1 | 1996 | 96 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 412 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2019 | 865 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18027 | 0.030 |
Why?
|
Athetosis | 1 | 1994 | 16 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2022 | 1348 | 0.030 |
Why?
|
Models, Genetic | 1 | 2005 | 3494 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3256 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5523 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3478 | 0.030 |
Why?
|
Algorithms | 2 | 2005 | 13885 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14726 | 0.030 |
Why?
|
Chorea | 1 | 1994 | 74 | 0.030 |
Why?
|
Immunoglobulin J-Chains | 1 | 2014 | 27 | 0.030 |
Why?
|
Facial Nerve | 1 | 1996 | 271 | 0.030 |
Why?
|
HLA Antigens | 1 | 2020 | 1382 | 0.030 |
Why?
|
Anemia | 1 | 2004 | 1504 | 0.030 |
Why?
|
Mice | 4 | 2014 | 81178 | 0.030 |
Why?
|
Genes, Dominant | 1 | 1996 | 880 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9685 | 0.030 |
Why?
|
Electrophysiology | 1 | 1996 | 1310 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 5867 | 0.030 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2014 | 173 | 0.030 |
Why?
|
Haplotypes | 1 | 2020 | 2781 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1720 | 0.030 |
Why?
|
Peptide Termination Factors | 1 | 2013 | 55 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2133 | 0.030 |
Why?
|
Chronic Disease | 2 | 2009 | 9147 | 0.030 |
Why?
|
Length of Stay | 1 | 2006 | 6308 | 0.030 |
Why?
|
Fibrosis | 1 | 2019 | 2029 | 0.030 |
Why?
|
Linear Models | 1 | 2002 | 5953 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 553 | 0.030 |
Why?
|
Meningococcal Vaccines | 1 | 2012 | 95 | 0.030 |
Why?
|
Child, Preschool | 3 | 2021 | 40992 | 0.020 |
Why?
|
Vaccines, Conjugate | 1 | 2012 | 333 | 0.020 |
Why?
|
Software | 1 | 2005 | 4442 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1996 | 770 | 0.020 |
Why?
|
Infant | 2 | 2021 | 35129 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1996 | 1255 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20123 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2004 | 3079 | 0.020 |
Why?
|
Adolescent | 3 | 2012 | 85759 | 0.020 |
Why?
|
Child | 4 | 2021 | 77679 | 0.020 |
Why?
|
Placebos | 1 | 2013 | 1677 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2013 | 13817 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 902 | 0.020 |
Why?
|
Phenotype | 2 | 2003 | 16365 | 0.020 |
Why?
|
Pain | 1 | 2002 | 4987 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 18116 | 0.020 |
Why?
|
Interleukins | 1 | 2011 | 791 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3129 | 0.020 |
Why?
|
Alzheimer Disease | 2 | 2005 | 8037 | 0.020 |
Why?
|
Blood Proteins | 1 | 2011 | 1123 | 0.020 |
Why?
|
Acute Disease | 1 | 1996 | 7148 | 0.020 |
Why?
|
Disease Progression | 1 | 2002 | 13280 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3846 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 2007 | 421 | 0.020 |
Why?
|
Necrosis | 1 | 2010 | 1643 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2010 | 599 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2004 | 9230 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2501 | 0.020 |
Why?
|
Prognosis | 1 | 2006 | 29050 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 25618 | 0.020 |
Why?
|
Exanthema | 1 | 2009 | 501 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2009 | 689 | 0.020 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2004 | 335 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10387 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2013 | 1708 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2013 | 1888 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7730 | 0.010 |
Why?
|
RNA | 1 | 2013 | 2749 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 255 | 0.010 |
Why?
|
Antibody Formation | 1 | 2007 | 1402 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13668 | 0.010 |
Why?
|
Medicare | 1 | 2018 | 6566 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4420 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2005 | 824 | 0.010 |
Why?
|
Troponin T | 1 | 2004 | 753 | 0.010 |
Why?
|
Risk Factors | 1 | 2006 | 72280 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2003 | 721 | 0.010 |
Why?
|
Probability | 1 | 2002 | 2505 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2004 | 19907 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4982 | 0.010 |
Why?
|
Cell Cycle | 1 | 2003 | 2967 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10634 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2009 | 3523 | 0.010 |
Why?
|
Sensation Disorders | 1 | 1994 | 156 | 0.010 |
Why?
|
Regeneration | 1 | 2002 | 1485 | 0.010 |
Why?
|
Myocardium | 1 | 2007 | 4776 | 0.010 |
Why?
|
Proprioception | 1 | 1994 | 132 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12801 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2003 | 2895 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5442 | 0.010 |
Why?
|
United States | 1 | 2018 | 69867 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15070 | 0.010 |
Why?
|
Genetic Variation | 1 | 2004 | 6546 | 0.010 |
Why?
|
Corpus Striatum | 1 | 1994 | 1220 | 0.000 |
Why?
|
Models, Biological | 1 | 2003 | 9582 | 0.000 |
Why?
|
Transcription Factors | 1 | 2005 | 12207 | 0.000 |
Why?
|
Neural Pathways | 1 | 1994 | 2972 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 1994 | 5709 | 0.000 |
Why?
|